☆ 4.7 Article

Curcumin Confers Anti-Inflammatory Effects in Adults Who Recovered from COVID-19 and Were Subsequently Vaccinated: A Randomized Controlled Trial

NUTRIENTS (2023)

Related references

Note: Only part of the references are listed.

Review Integrative & Complementary Medicine

Profiling Inflammatory Biomarkers following Curcumin Supplementation: An Umbrella Meta-Analysis of Randomized Clinical Trials

Navid Naghsh et al.

Summary: The umbrella meta-analysis suggests that curcumin can effectively reduce the levels of inflammatory biomarkers, especially C-reactive protein, interleukin 6, and tumor necrosis factor alpha. It can be used as an adjunctive therapeutic approach in diseases with elevated levels of inflammatory biomarkers.

EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2023)

Add to Collection

Article Biochemistry & Molecular Biology

Infectiousness of SARS-CoV-2 breakthrough infections and reinfections during the Omicron wave

Sophia T. Tan et al.

Summary: The study found that both vaccine-derived and naturally acquired immunity can reduce the infectiousness of individuals with Omicron variant SARS-CoV-2 infections in a prison setting. Vaccinated individuals, especially those who received booster doses and were recently vaccinated, have lower infectiousness.

NATURE MEDICINE (2023)

Add to Collection

Review Biochemistry & Molecular Biology

Antioxidant and anti-inflammatory effects of curcumin/turmeric supplementation in adults: A GRADE-assessed systematic review and dose-response meta-analysis of randomized controlled trials

Mohammad Jafar Dehzad et al.

Summary: This systematic review and meta-analysis summarized the existing literature on the impact of turmeric and its bioactive compound curcumin on inflammatory and oxidative balance. The results showed that turmeric/curcumin supplementation significantly reduces inflammatory markers and improves antioxidant activity, suggesting its potential as a viable intervention for improving inflammatory/oxidative status.

CYTOKINE (2023)

Add to Collection

Article Medicine, General & Internal

Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants

Emma K. Accorsi et al.

Summary: Assessing the performance of COVID-19 vaccines against the Omicron variant is crucial for public health guidance. This study found that receiving three doses of mRNA COVID-19 vaccine was associated with a lower likelihood of symptomatic SARS-CoV-2 infection compared to being unvaccinated or receiving two doses. These findings suggest that three doses of mRNA vaccine provide protection against both Omicron and Delta variants, though the protection against Omicron may be slightly lower.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

Add to Collection

Article Immunology

Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection

Chansavath Phetsouphanh et al.

Summary: Phetsouphanh and colleagues found that individuals with long COVID exhibit persistent activation of the immune system even 8 months after infection. They also identified a set of analytes associated with long COVID, suggesting potential opportunities for prevention and treatment.

NATURE IMMUNOLOGY (2022)

Add to Collection

Review Immunology

Pathological sequelae of long-haul COVID

Saurabh Mehandru et al.

Summary: This review examines the underlying pathophysiological mechanisms of post-COVID-19 syndromes, including persistent inflammation, induced autoimmunity, and putative viral reservoirs. The disease is called 'long-haul COVID' or 'post-COVID-19 syndrome', and clinical symptoms include fatigue, dyspnea, and neuropsychiatric syndromes.

NATURE IMMUNOLOGY (2022)

Add to Collection

Letter Medicine, General & Internal

Protection against the Omicron Variant from Previous SARS-CoV-2 Infection

Heba N. Altarawneh et al.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection

Article Public, Environmental & Occupational Health

COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster Doses During Periods of Delta and Omicron Variant Emergence — 25 U.S. Jurisdictions, April 4–December 25, 2021

Amelia G. Johnson et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2022)

Add to Collection

Article Multidisciplinary Sciences

Catechin and curcumin interact with S protein of SARS-CoV2 and ACE2 of human cell membrane: insights from computational studies

Atala B. Jena et al.

Summary: This study demonstrates that catechin and curcumin exhibit strong binding affinity to viral S Protein and host receptor ACE2, as well as their complex, which may offer a therapeutic strategy against SARS-CoV2.

SCIENTIFIC REPORTS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Attributes and predictors of long COVID

Carole H. Sudre et al.

Summary: Reports on long-lasting COVID-19 symptoms, known as 'long COVID', are increasing. Analysis of data from over 4,000 COVID-19 cases revealed that long COVID is more common in older individuals, those with higher body mass index, and females. Experiencing more than five symptoms in the first week of illness was associated with long COVID. A simple model showed promise in distinguishing between short and long COVID cases early in the disease.

NATURE MEDICINE (2021)

Add to Collection

Article Multidisciplinary Sciences

Integrated cytokine and metabolite analysis reveals immunometabolic reprogramming in COVID-19 patients with therapeutic implications

Nan Xiao et al.

Summary: Metabolomic data and cytokine/chemokine profiling from stratified COVID-19 patients suggest a correlation between arginine, tryptophan, and purine metabolic pathways with hyperinflammation, potentially offering therapeutic targets for severe COVID-19 patients. Modulating metabolism can significantly impact the release of proinflammatory cytokines by peripheral blood mononuclear cells, indicating a potential strategy for treating fatal cytokine release syndrome in COVID-19.

NATURE COMMUNICATIONS (2021)

Add to Collection

Article Multidisciplinary Sciences

Years of life lost to COVID-19 in 81 countries

Hector Pifarre i Arolas et al.

Summary: The study reveals a significant loss of years of life due to COVID-19 globally, especially in heavily affected countries. The majority of these lost years are from deaths under 75 years old, particularly those under 55, with men losing 45% more life years than women. These findings emphasize the need for policies that protect vulnerable demographics with the highest loss of life-years.

SCIENTIFIC REPORTS (2021)

Add to Collection

Review Chemistry, Medicinal

Anti-Inflammatory Effects of Curcumin in the Inflammatory Diseases: Status, Limitations and Countermeasures

Ying Peng et al.

Summary: Curcumin, a natural compound, shows great potential in disease treatment with its significant anti-inflammatory effect. It has been proven to effectively improve symptoms of inflammatory diseases, making it a promising candidate for related disease treatments.

DRUG DESIGN DEVELOPMENT AND THERAPY (2021)

Add to Collection

Review Nutrition & Dietetics

Nutrition and immunity: lessons for COVID-19

Philip C. Calder

Summary: The immune system protects individuals from pathogenic organisms, with good nutrition supporting immune response. Older people, individuals living with obesity, and those who are malnourished are at higher risk of impaired immunity, especially after infection with SARS-CoV-2. Studies suggest that individual micronutrients like vitamin D and zinc may play a role in reducing the severity of infection with SARS-CoV-2.

EUROPEAN JOURNAL OF CLINICAL NUTRITION (2021)

Add to Collection

Article Medicine, General & Internal

Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings

M. G. Thompson et al.

Summary: A study with a test-negative design analyzed 41,552 admissions to 187 hospitals and 21,522 visits to 221 EDs or urgent care clinics. The mRNA-based vaccines (>= 14 days after the second dose) were highly effective against SARS-CoV-2 infection leading to hospitalization (89%), ICU admission (90%), or an urgent care visit (91%).

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

Covid-19 Breakthrough Infections in Vaccinated Health Care Workers

Moriah Bergwerk et al.

Summary: Among fully vaccinated health care workers, breakthrough infections with SARS-CoV-2 were correlated with neutralizing antibody titers during the peri-infection period. Most breakthrough infections were mild or asymptomatic, although persistent symptoms did occur.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Review Biochemistry & Molecular Biology

The signal pathways and treatment of cytokine storm in COVID-19

Lan Yang et al.

Summary: The COVID-19 pandemic is a global crisis with devastating effects, where immunopathology plays a crucial role in disease progression, particularly the cytokine storm which has a significant impact on prognosis. Understanding and targeting the pathways involved in cytokine storm could lead to more effective treatment strategies for COVID-19.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Add to Collection

Review Immunology

IL-6 in inflammation, autoimmunity and cancer

Toshio Hirano

Summary: IL-6 is involved in various physiological processes including immune responses and inflammation. It plays a crucial role in chronic inflammation and cytokine storms, such as seen in COVID-19. The IL-6 amplifier, involving NF-kappa B and STAT3, is a key mechanism in promoting uncontrolled inflammatory responses.

INTERNATIONAL IMMUNOLOGY (2021)

Add to Collection

Review Multidisciplinary Sciences

Antiviral and immunomodulatory activity of curcumin: A case for prophylactic therapy for COVID-19

Rajesh K. Thimmulappa et al.

Summary: COVID-19, caused by SARS-CoV-2, has led to a significant number of cases and deaths. Curcumin, a bioactive compound in turmeric, is considered a potential prophylactic therapeutic for COVID-19.

HELIYON (2021)

Add to Collection

Letter Medicine, General & Internal

COVID-19: consider cytokine storm syndromes and immunosuppression

Puja Mehta et al.

LANCET (2020)

Add to Collection

Article Multidisciplinary Sciences

Increased interleukin-6 and macrophage chemoattractant protein-1 are associated with respiratory failure in COVID-19

Marthe Jontvedt Jorgensen et al.

SCIENTIFIC REPORTS (2020)

Add to Collection

Article Public, Environmental & Occupational Health

The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine — United States, December 2020

Sara E. Oliver et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)

Add to Collection

Article Nutrition & Dietetics

Increased bioavailability of curcumin using a novel dispersion technology system (LipiSperse®)

D. Briskey et al.

EUROPEAN JOURNAL OF NUTRITION (2019)

Add to Collection

Article Cell Biology

Curcumin attenuates proangiogenic and proinflammatory factors in human eutopic endometrial stromal cells through the NF-κB signaling pathway

Indrajit Chowdhury et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2019)

Add to Collection

Article Biochemistry & Molecular Biology

Direct pulmonary delivery of solubilized curcumin reduces severity of lethal pneumonia

Boya Zhang et al.

FASEB JOURNAL (2019)

Add to Collection

Review Pharmacology & Pharmacy

Oral turmeric/curcumin effects on inflammatory markers in chronic inflammatory diseases: A systematic review and meta-analysis of randomized controlled trials

C. Michael White et al.

PHARMACOLOGICAL RESEARCH (2019)

Add to Collection

Article Cell Biology

Curcumin Attenuates Airway Inflammation and Airway Remolding by Inhibiting NF-B Signaling and COX-2 in Cigarette Smoke-Induced COPD Mice

Jin Yuan et al.

INFLAMMATION (2018)

Add to Collection

Article Immunology

Inhibition of curcumin on influenza A virus infection and influenzal pneumonia via oxidative stress, TLR2/4, p38/JNK MAPK and NF-kappa B pathways

Jianping Dai et al.

INTERNATIONAL IMMUNOPHARMACOLOGY (2018)

Add to Collection

Article Immunology

Curcumin Suppresses IL-1β Secretion and Prevents Inflammation through Inhibition of the NLRP3 Inflammasome

Haipeng Yin et al.

JOURNAL OF IMMUNOLOGY (2018)

Add to Collection

Review Nutrition & Dietetics

Bioactivity, Health Benefits, and Related Molecular Mechanisms of Curcumin: Current Progress, Challenges, and Perspectives

Xiao-Yu Xu et al.

NUTRIENTS (2018)

Add to Collection

Review Food Science & Technology

The emerging role of curcumin for improving vascular dysfunction: A review

Marilyn S. Campbell et al.

CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2018)

Add to Collection

Article Pharmacology & Pharmacy

Curcumin ameliorates severe influenza pneumonia via attenuating lung injury and regulating macrophage cytokines production

Shuguang Han et al.

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2018)

Add to Collection

Review Pharmacology & Pharmacy

Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases

Ajaikumar B. Kunnumakkara et al.

BRITISH JOURNAL OF PHARMACOLOGY (2017)

Add to Collection

Article Pharmacology & Pharmacy

Curcumin inhibits Zika and chikungunya virus infection by inhibiting cell binding

Bryan C. Mounce et al.

ANTIVIRAL RESEARCH (2017)

Add to Collection

Review Pharmacology & Pharmacy

Oral bioavailability of curcumin: problems and advancements

Weidong Liu et al.

JOURNAL OF DRUG TARGETING (2016)

Add to Collection

Review Pharmacology & Pharmacy

Effect of curcumin on circulating interleukin-6 concentrations: A systematic review and meta-analysis of randomized controlled trials

Giuseppe Derosa et al.

PHARMACOLOGICAL RESEARCH (2016)

Add to Collection

Article Multidisciplinary Sciences

Effects of IL-1β, IL-6 and IL-8 on erythrocytes, platelets and clot viscoelasticity

Janette Bester et al.

SCIENTIFIC REPORTS (2016)

Add to Collection

Article Gastroenterology & Hepatology

Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells

Anggakusuma et al.

GUT (2014)

Add to Collection

Review Oncology

Recent Developments in Delivery, Bioavailability, Absorption and Metabolism of Curcumin: the Golden Pigment from Golden Spice

Sahdeo Prasad et al.

CANCER RESEARCH AND TREATMENT (2014)

Add to Collection

Article Multidisciplinary Sciences

Curcumin Modulates the Inflammatory Response and Inhibits Subsequent Fibrosis in a Mouse Model of Viral-induced Acute Respiratory Distress Syndrome

Sreedevi Avasarala et al.

PLOS ONE (2013)

Add to Collection

Article Oncology

Endogenous PGE2 induces MCP-1 expression via EP4/p38 MAPK signaling in melanoma

Mingrui Tang et al.

ONCOLOGY LETTERS (2013)

Add to Collection

Article Cell Biology

Curcumin inhibits ox-LDL-induced MCP-1 expression by suppressing the p38MAPK and NF-κB pathways in rat vascular smooth muscle cells

Yi Zhong et al.

INFLAMMATION RESEARCH (2012)

Add to Collection

Article Plant Sciences

Curcumin attenuates allergic airway inflammation and hyper-responsiveness in mice through NF-κB inhibition

Se-Woong Oh et al.

JOURNAL OF ETHNOPHARMACOLOGY (2011)

Add to Collection

Review Allergy

Innate and adaptive immunosenescence

Shradha Agarwal et al.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2010)

Add to Collection

Article Immunology

Tumor necrosis factor-alpha up-regulates the expression of CCL2 and adhesion molecules of human proximal tubular epithelial cells through MAPK signaling pathways

Amy Wing Yin Ho et al.

IMMUNOBIOLOGY (2008)

Add to Collection

Review Medicine, Research & Experimental

Bioavailability of curcumin: Problems and promises

Preetha Anand et al.

MOLECULAR PHARMACEUTICS (2007)

Add to Collection

Review Physiology

Chemokines and chemokine receptors in leukocyte trafficking

TS Olson et al.

AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2002)

Add to Collection

© Peeref 2019-2024. All rights reserved.